299 related articles for article (PubMed ID: 11850796)
21. Telomerase activity in vivo in human malignant hematopoietic cells.
Nilsson P; Mehle C; Remes K; Roos G
Oncogene; 1994 Oct; 9(10):3043-8. PubMed ID: 8084612
[TBL] [Abstract][Full Text] [Related]
22. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
[TBL] [Abstract][Full Text] [Related]
23. Telomerase regulation and progressive telomere shortening of rat hepatic stem-like epithelial cells during in vitro aging.
Oh BK; Lee CH; Park C; Park YN
Exp Cell Res; 2004 Aug; 298(2):445-54. PubMed ID: 15265692
[TBL] [Abstract][Full Text] [Related]
24. Telomerase regulation in hematological cancers: a matter of stemness?
Deville L; Hillion J; Ségal-Bendirdjian E
Biochim Biophys Acta; 2009 Apr; 1792(4):229-39. PubMed ID: 19419697
[TBL] [Abstract][Full Text] [Related]
25. Telomeres and aging.
Aubert G; Lansdorp PM
Physiol Rev; 2008 Apr; 88(2):557-79. PubMed ID: 18391173
[TBL] [Abstract][Full Text] [Related]
26. Determination of telomerase activity and telomere length.
Wu KD; Moore MA
Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
[TBL] [Abstract][Full Text] [Related]
27. The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation.
Wang L; Xiao H; Zhang X; Wang C; Huang H
J Hematol Oncol; 2014 Aug; 7():61. PubMed ID: 25139287
[TBL] [Abstract][Full Text] [Related]
28. Lack of correlation between telomere length and telomerase activity and expression in leukemic cells.
Januszkiewicz D; Wysoki J; Lewandowski K; Pernak M; Nowicka K; Rembowska J; Nowak J
Int J Mol Med; 2003 Dec; 12(6):935-8. PubMed ID: 14612969
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
Bitisik O; Yavuz S; Yasasever V; Dalay N
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
[TBL] [Abstract][Full Text] [Related]
30. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
[TBL] [Abstract][Full Text] [Related]
31. Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
Keller G; Brassat U; Braig M; Heim D; Wege H; Brümmendorf TH
Hematol Oncol; 2009 Sep; 27(3):123-9. PubMed ID: 19569255
[TBL] [Abstract][Full Text] [Related]
32. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
El Daly H; Martens UM
Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
[TBL] [Abstract][Full Text] [Related]
33. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
Arkus N
J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
[TBL] [Abstract][Full Text] [Related]
34. Telomerase as a clinical target: current strategies and potential applications.
Fleisig HB; Wong JM
Exp Gerontol; 2007; 42(1-2):102-12. PubMed ID: 16814507
[TBL] [Abstract][Full Text] [Related]
35. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
36. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
37. Use of telomerase to create bioengineered tissues.
Shay JW; Wright WE
Ann N Y Acad Sci; 2005 Dec; 1057():479-91. PubMed ID: 16399914
[TBL] [Abstract][Full Text] [Related]
38. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
39. Role of telomerase in hematopoietic stem cells.
Lansdorp PM
Ann N Y Acad Sci; 2005 Jun; 1044():220-7. PubMed ID: 15958715
[TBL] [Abstract][Full Text] [Related]
40. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
Hao LY; Armanios M; Strong MA; Karim B; Feldser DM; Huso D; Greider CW
Cell; 2005 Dec; 123(6):1121-31. PubMed ID: 16360040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
